Baird Medical Investment (BDMD) Competitors $2.00 -0.05 (-2.44%) As of 04:00 PM Eastern Add Compare Share Share Competitors Stock AnalysisChartCompetitorsHeadlinesOwnershipSEC FilingsTrendsBuy This Stock BDMD vs. RBOT, CTCX, MDAI, INO, PYPD, QTI, DXR, APT, SRTS, and EDAPShould you be buying Baird Medical Investment stock or one of its competitors? The main competitors of Baird Medical Investment include Vicarious Surgical (RBOT), Carmell (CTCX), Spectral AI (MDAI), Inovio Pharmaceuticals (INO), PolyPid (PYPD), QT Imaging (QTI), Daxor (DXR), Alpha Pro Tech (APT), Sensus Healthcare (SRTS), and Edap Tms (EDAP). These companies are all part of the "medical equipment" industry. Baird Medical Investment vs. Its Competitors Vicarious Surgical Carmell Spectral AI Inovio Pharmaceuticals PolyPid QT Imaging Daxor Alpha Pro Tech Sensus Healthcare Edap Tms Baird Medical Investment (NASDAQ:BDMD) and Vicarious Surgical (NYSE:RBOT) are both small-cap medical companies, but which is the superior stock? We will contrast the two businesses based on the strength of their dividends, valuation, risk, profitability, media sentiment, analyst recommendations, earnings and institutional ownership. Is BDMD or RBOT more profitable? Baird Medical Investment's return on equity of 0.00% beat Vicarious Surgical's return on equity.Company Net Margins Return on Equity Return on Assets Baird Medical InvestmentN/A N/A N/A Vicarious Surgical N/A -148.14%-98.07% Does the media prefer BDMD or RBOT? In the previous week, Vicarious Surgical had 2 more articles in the media than Baird Medical Investment. MarketBeat recorded 2 mentions for Vicarious Surgical and 0 mentions for Baird Medical Investment. Vicarious Surgical's average media sentiment score of 0.13 beat Baird Medical Investment's score of 0.00 indicating that Vicarious Surgical is being referred to more favorably in the news media. Company Overall Sentiment Baird Medical Investment Neutral Vicarious Surgical Neutral Do analysts recommend BDMD or RBOT? Vicarious Surgical has a consensus target price of $7.00, suggesting a potential upside of 9.12%. Given Vicarious Surgical's stronger consensus rating and higher probable upside, analysts clearly believe Vicarious Surgical is more favorable than Baird Medical Investment.Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score Baird Medical Investment 0 Sell rating(s) 0 Hold rating(s) 0 Buy rating(s) 0 Strong Buy rating(s) 0.00Vicarious Surgical 0 Sell rating(s) 1 Hold rating(s) 0 Buy rating(s) 0 Strong Buy rating(s) 2.00 Which has more volatility & risk, BDMD or RBOT? Baird Medical Investment has a beta of -1, indicating that its stock price is 200% less volatile than the S&P 500. Comparatively, Vicarious Surgical has a beta of 1.41, indicating that its stock price is 41% more volatile than the S&P 500. Which has better earnings and valuation, BDMD or RBOT? CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings RatioBaird Medical InvestmentN/AN/AN/AN/AN/AVicarious SurgicalN/AN/A-$63.22M-$10.09-0.64 Do institutionals and insiders hold more shares of BDMD or RBOT? 19.8% of Baird Medical Investment shares are owned by institutional investors. Comparatively, 47.3% of Vicarious Surgical shares are owned by institutional investors. 78.9% of Baird Medical Investment shares are owned by company insiders. Comparatively, 12.0% of Vicarious Surgical shares are owned by company insiders. Strong institutional ownership is an indication that hedge funds, endowments and large money managers believe a company is poised for long-term growth. SummaryVicarious Surgical beats Baird Medical Investment on 6 of the 9 factors compared between the two stocks. Get Baird Medical Investment News Delivered to You Automatically Sign up to receive the latest news and ratings for BDMD and its competitors with MarketBeat's FREE daily newsletter. Email Address New MarketBeat Followers Over TimeWhat are MarkeBeat Followers?This chart shows the number of new MarketBeat users adding BDMD and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period. Skip ChartMedia Sentiment Over TimeWhat is Media Sentiment?This chart shows the average media sentiment of NASDAQ and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.Skip Chart BDMD vs. The Competition Export to ExcelMetricBaird Medical InvestmentMED INSTRUMENTS IndustryMedical SectorNASDAQ ExchangeMarket Cap$71.46M$6.82B$5.74B$9.56BDividend YieldN/A1.29%4.53%4.07%P/E RatioN/A26.3930.4325.14Price / SalesN/A66.68392.4187.63Price / CashN/A21.6837.0358.50Price / BookN/A6.718.956.21Net IncomeN/A$176.42M$3.26B$265.38M7 Day Performance-22.48%-2.78%1.03%-1.12%1 Month Performance-34.64%-2.53%4.28%-0.68%1 Year PerformanceN/A7.40%28.38%18.92% Baird Medical Investment Competitors List Export to ExcelCompanyMarketRankShare PriceAnalysts' Price Target1Y Price PerformanceMarket CapRevenueP/E RatioEmployee CountIndicator(s)BDMDBaird Medical InvestmentN/A$2.00-2.4%N/AN/A$71.46MN/A0.00N/ARBOTVicarious Surgical0.8176 of 5 stars$9.95+8.2%$8.50-14.6%-6.0%$58.26MN/A-0.94210CTCXCarmellN/A$2.70-4.6%N/A+204.0%$56.44M$32.84K0.0014MDAISpectral AI3.184 of 5 stars$2.18-7.8%$3.50+60.9%+33.3%$55.07M$29.58M-4.0383Analyst RevisionINOInovio Pharmaceuticals4.0373 of 5 stars$1.48+2.4%$8.80+496.6%-74.9%$54.09M$220K-0.46320Analyst RevisionPYPDPolyPid2.6888 of 5 stars$3.26+0.9%$11.80+262.0%-2.2%$51.91MN/A-0.7680Analyst RevisionQTIQT ImagingN/A$1.90+2.7%N/A+331.0%$51.56M$4.00M0.00N/ADXRDaxor4.1661 of 5 stars$10.65+5.6%$25.00+134.7%+25.4%$51.55MN/A0.0037Short Interest ↓APTAlpha Pro Tech0.9283 of 5 stars$4.70+1.3%N/A-27.2%$51.06M$58.18M12.70120Negative NewsShort Interest ↑SRTSSensus Healthcare1.7679 of 5 stars$3.09-2.8%$8.00+158.9%-53.4%$50.80M$41.81M-51.5040EDAPEdap Tms2.9828 of 5 stars$1.36+7.5%$8.50+527.3%-67.3%$50.66M$69.18M-2.19230News CoverageUpcoming EarningsShort Interest ↓ Related Companies and Tools Related Companies RBOT Competitors CTCX Competitors MDAI Competitors INO Competitors PYPD Competitors QTI Competitors DXR Competitors APT Competitors SRTS Competitors EDAP Competitors Top 10 Stock Comparisons Semiconductor Stocks Artificial Intelligence Stocks Growth Stocks Magnificent Seven Stocks Pharmaceutical Stocks Ecommerce Stocks Bitcoin Stocks Meme Stocks Cryptocurrency Stocks Cybersecurity Stocks This page (NASDAQ:BDMD) was last updated on 8/21/2025 by MarketBeat.com Staff From Our PartnersTrump’s national nightmare is herePorter Stansberry and Jeff Brown say a new U.S. national emergency is already underway — and it could trigger ...Porter & Company | SponsoredMarket Panic: Trump Just Dropped a Bomb on Your Stockstock Market Panic: Trump Just Dropped a Bomb on Your Stocks The market is in freefall—and Trump's new tarif...American Alternative | SponsoredAlex’s “Next Magnificent Seven” stocksThe original “Magnificent Seven” turned $7K into $1.18 million. Now, Alex Green has identified AI’s Next Ma...The Oxford Club | SponsoredBONUS GUIDE - Ben Stein Prepares For the Next Financial CrisisWith inflation high, debt soaring, and global tensions rising, a financial storm may be brewing. Economist ...Goldco Precious Metals | SponsoredOut of 18,347 Cryptocurrencies... This is the ONLY OneThe Single Most Undervalued DeFi Protocol You've Never Heard Of If there's one cryptocurrency you should b...Crypto 101 Media | SponsoredGENIUS Act: Cancel Your Money?A new law called the GENIUS Act could quietly trigger the most radical shift in American finance in decades. B...Priority Gold | SponsoredElon’s Secret Social Security BombshellTo All Americans Born Before April 16th, 1963: Did Trump Just Give The Green Light To Radically RE-DO Social S...Banyan Hill Publishing | SponsoredINVESTOR ALERT: Tiny “$3 AI Wonder Stock” on the Verge of Blasting OffRight now, we’re witnessing a monumental shift in the world.Traders Agency | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added ten stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Baird Medical Investment Holdings Limited Please log in to your account or sign up in order to add this asset to your watchlist. Share Baird Medical Investment With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
MarketBeat All Access